Audience Response. Hypertension. Case: Mr. J. Measuring BP. Non-pharmacologic intervention. Case: Mr. J. Session ID: HTN411

Similar documents
RESISTENT HYPERTENSION. Dr. Helmy Bakr Professor and Head of Cardiology Dept. Mansoura University

Difficult-to-Control & Resistant Hypertension. Anthony Viera, MD, MPH, FAHA Professor and Chair

Hypertension Update. Sarah J. Payne, MS, PharmD, BCPS Assistant Professor, Department of Pharmacotherapy UNT System College of Pharmacy

Pharmacologic Management of Hypertension

Hypertension CHAPTER-I CARDIOVASCULAR SYSTEM. Dr. K T NAIK Pharm.D Associate Professor Department of Pharm.D Krishna Teja Pharmacy College, Tirupati

Hypertension Update. Objectives 4/28/2015. Beverly J. Mathis, D.O. OOA May 2015

Treating Hypertension from

ADVANCES IN MANAGEMENT OF HYPERTENSION

Management of Hypertension. M Misra MD MRCP (UK) Division of Nephrology University of Missouri School of Medicine

MODERN MANAGEMENT OF HYPERTENSION Where Do We Draw the Line? Disclosure. No relevant financial relationships. Blood Pressure and Risk

Jared Moore, MD, FACP

Hypertension Pharmacotherapy: A Practical Approach

Hypertension Update Background

HypertensionTreatment Guidelines. Michaelene Urban APRN, MSN, ACNS-BC, ANP-BC

Management of Hypertension. Ahmed El Hawary MD Suez Canal University

Approach to patient with hypertension. Dr. Amitesh Aggarwal

How to approach resistant hypertension. Teh-Li Huo, M.D., Ph.D.

Hypertension Update. Aaron J. Friedberg, MD

ADVANCES IN MANAGEMENT OF HYPERTENSION

Managing Hypertension in 2016

Diagnosis and treatment of hypertension. Kari Nelson, MD MSHS Division of General Internal Medicine VA Puget Sound, University of Washington

Preventing and Treating High Blood Pressure

Antihypertensive drugs: I. Thiazide and other diuretics:

Hypertension (JNC-8)

Objectives. JNC 7 Is Nice But What s Up With JNC 8? Why Do We Care? Hypertension Background: Prevalence

Update in Hypertension

VA/DoD Clinical Practice Guideline for the Diagnosis and Management of Hypertension - Pocket Guide Update 2004 Revision July 2005

MANAGEMENT OF HYPERTENSION: TREATMENT THRESHOLDS AND MEDICATION SELECTION

New Hypertension Guidelines. Kofi Osei, MD

Management of High Blood Pressure in Adults

Difficult to Treat Hypertension

Modern Management of Hypertension: Where Do We Draw the Line?

hypertension Head of prevention and control of CVD disease office Ministry of heath

Hypertension Management Controversies in the Elderly Patient

Secondary Hypertension: A Real World Approach

Hypertension diagnosis (see detail document) Diabetic. Target less than 130/80mmHg

Modern Management of Hypertension

SAURIN GANDHI, AZCOM Evidence-Based Guideline for the Management of High Blood Pressure in Adults (JNC 8)

MANAGEMENT OF HYPERTENSION IN PREGNANCY, THE ALGORHITHM

Hypertension: JNC-7. Southern California University of Health Sciences Physician Assistant Program

Hypertension in the very old. Objectives: Clinical Perspective

Approach to Management of Hypertension. Prof. Abdulkareem Al-Suwaida, MD, FRCPC, MSc

Reframe the Paradigm of Hypertension treatment Focus on Diabetes

Hypertension Management - Summary

Diabetes and Hypertension

COMPLEX HYPERTENSION. Anita Ralstin, FNP-BC Next Step Health Consultant, LLC

Incidental Findings; Management of patients presenting with high BP. Phil Swales

Hypertension Update Clinical Controversies Regarding Age and Race

The Latest Generation of Clinical

Hypertension. Most important public health problem in developed countries

Management of Hypertension

A CASE OF HYPERTENSION AND ACUTE RENAL FAILURE OBJECTIVES

Systemic Hypertension Dr ahmed almutairi Assistant professor Internal medicine dept

7/7/ CHD/MI LVH and LV dysfunction Dysrrhythmias Stroke PVD Renal insufficiency and failure Retinopathy. Normal <120 Prehypertension

Introductory Clinical Pharmacology Chapter 41 Antihypertensive Drugs

Hypertension. Does it Matter What Medications We Use? Nishant K. Sekaran, M.D. M.Sc. Intermountain Heart Institute

Agenda. Management of Accelerated Hypertension (Updated in 2017) Salwa Roshdy Prof. of Cardiology Assiut University CardioEgypt 23/2/2017 2/27/2017

Endocrine. Endocrine as it relates to the kidney. Sarah Elfering, MD University of Minnesota

What in the World is Functional Medicine?

Getting BP to goal: Virginia L. Hood MB.BS, MPH, FACP

HYPERTENSION. Background for understanding the Hypertension literature. Case presentation. Approach to Treatment. Jeffrey J. Kaufhold, MD Nephrology

Blood Pressure Treatment in 2018


Younger adults with a family history of premature artherosclerotic disease should have their cardiovascular risk factors measured.

Difficult to Control HTN: It is not all the same. Structured approach to evaluation and treatment

Creative blood pressure management: whys and the tricks

We are delighted to have Dr. Roetzheim with us today to discuss Managing Hypertension in Older Adult Patients.

Management of Hypertension in Women

Hypertension in the Era of ACC/AHA: Practice Changing Evidence and Recommendations

RESISTANT HYPERTENSION

Summary of recommendations

Dr Doris M. W Kinuthia

New Lipid Guidelines. PREVENTION OF CARDIOVASCULAR DISEASE IN WOMEN: Implications of the New Guidelines for Hypertension and Lipids.

Chapter 23. Media Directory. Cardiovascular Disease (CVD) Hypertension: Classified into Three Categories

Hypertension Cases. Katharine Dahl, MD January 10, 2017

How to Recognize Adrenal Disease

5.2 Key priorities for implementation

Hypertension Management: A Moving Target

What is hypertension?

Hypertension. Risk of cardiovascular disease beginning at 115/75 mmhg doubles with every 20/10mm Hg increase. (Grade B)

Hypertensive Crises. Controlling high blood pressure prevents disease. Recognition and Management of Acute Hypertensive Emergencies

Antihypertensive Agents

Hypertension 2015: Recent Evidence that Will Change Your Practice

Approach to Adrenal Incidentaloma. Alice Y.Y. Cheng, MD, FRCP

major public health burden

2014 HYPERTENSION GUIDELINES

Objectives. Heart failure and Hypertension. Definition & epidemiology of heart failure HEART FAILURE 3/12/2016. Kirsten Bibbins-Domingo, PhD, MD, MAS

The New Hypertension Guidelines

Practical Aspects of Hypertension: Simple Strategies to Help You and Your Patients Meet Guideline Blood Pressure Targets

Hypertensives Emergency and Urgency

Combination Therapy for Hypertension

Joshua M. Crasner,DO,FACC,FACOI

Adult Blood Pressure Clinician Guide June 2018

SECONDARY HYPERTENSION

Management of Lipid Disorders and Hypertension: Implications of the New Guidelines

How do I investigate suspected secondary hypertension? Marie Freel RCP Update in Medicine 23 rd November 2016

Network Hypertension Algorithm

INDIAN HYPERTENSION GUIDELINES-II

Diseases of the Adrenal gland

Transcription:

Audience Response http://rwpoll.com OR App downloads: Hypertension Chris Knight, MD cknight@uw.edu http://tiny.cc/rwiphone http://tiny.cc/rwdroid Session ID: HTN411 Case: Mr. J 52 y/o male patient comes in for evaluation of elevated BP. BP noted to be 148/88 in grocery store, now 138/86 p 84; otherwise healthy, asymptomatic. BMI 28, no regular exercise program. All of these make sense EXCEPT? A. 24-hour ambulatory monitoring B. Dietary counseling C. Exercise recommendations D. Fasting lipids, glucose E. Start hydrochlorothiazide Measuring BP Home BP monitoring 1/2 of patients have home measurements 10 mmhg or more lower than office Better correlated with end organ damage Multiple readings (home or office) more reliable Non-pharmacologic intervention Weight loss: 5-20 mmhg/10 kg DASH diet: 8-14 mmhg Salt restriction: 2-8 mmhg Exercise: 4-9 mmhg Alcohol moderation: 2-4 mmhg Case: Mr. J Mr. J comes back 4 months later. He now goes to the gym twice a week and pays more attention to salt but still eats at restaurants frequently. His LDL is 141, HDL 42. Home BP has been 135-155/85-95 for the most part; today his BP is 146/92, p 80. All of these make sense EXCEPT? A. Urinalysis C. Basic metabolic panel D. Albumin/creatinine ratio E. Do them all

Prevalence and impact Initial Evaluation Fasting lipids, glucose (Risk factor mod.) 90% lifetime risk at age 55 Risk of CVD doubles for each 20/10 > 115/75 BMP (K+, egfr) UA (for glomerulonephritis) Albumin/creatinine ratio (proteinuria) Consider EKG (for LVH) Case: Mr. J Mr. J reluctantly got his labs (he hates needles): K + 4.1, TC 190, HDL 60, Glucose 89, egfr > 60; Alb/cre ratio 8. The two of you decide to try a medication. Which do you prescribe? A. Amlodipine 5 mg daily B. Chlorthalidone 12.5 mg daily C. Atenolol 25 mg daily D. Hydrochlorothiazide 25 mg daily E. Lisinopril 10 mg daily Treatment Thiazide diuretics are particularly effective Chlorthalidone is twice as potent and has longer 1/2 life than HCTZ, but more hypokalemia ACEI, CCB also well studied as monotherapy CCB requires less monitoring Treatment Amlodipine + ACEI may have additional cardiovascular benefit ß-blockers (esp. atenolol) somewhat less effective at reducing stroke Most effective drug is the one the patient will take: fewer pills, fewer doses are good! Case: Mrs. S A 59 y/o woman with type 2 diabetes comes to your clinic as a new patient. She takes insulin, atorvastatin, and hydrochlorothiazide 25 mg daily for hypertension. Her BP is 133/84, HR 84. Labs show a hemoglobin A1C of 7.1% and urinary albumin/ creatinine ratio of 45. The best next step for her is: A. Home BP monitoring B. Discuss therapeutic lifestyle changes C. Add lisinopril 5 mg daily D. Add atenolol 25 mg daily E. 24-hour urine for protein excretion

Targets JNC 7, general: <140/90--but lower (<130)is better if you can get there JNC 7, DM/CKD: <130/80; more important in pts with protenuria Other diseases with lower targets: CHF, Aortic dissection, ASCVD Increased mortality when DBP < 60 with CAD? Specific indications for certain drugs CKD with proteinuria: ACE/ARB CHF: ACE/ARB, ß-blocker, aldosterone antagonists (low dose), diuretics Diabetes: Diuretics, ACE/ARB, ß-blocker, CCB Post-MI: ß-blocker, ACE (ARB?), aldosterone antagonist Case: Mrs. L A 85 y/o woman comes to your office as a new patient to discuss her blood pressure. She has been watching it at home, and it s typically 160-170/80-90. BMI is 22. She walks for 30 minutes 3 times weekly, eats a low sodium diet, and takes no medications. Your BP target for her would be: A. 140-150/80-90 B. 120-130/70-80 C. No evidence to support treatment Hypertension in the Elderly Isolated systolic hypertension more common Data limited in pts over 80; HyVET showed benefit with target 150/80 Beware orthostasis, polypharmacy Reasonable to target 140-150/80-90 and adjust target based on comorbidities Case: Mr. C A 75 y/o gentleman comes in for follow-up of hypertension. He is on hydrochlorothiazide 25 mg daily, lisinopril 40 mg daily, and amlodipine 10 mg daily. His blood pressure is sometimes well controlled, others not; today it is 180/100, pulse 64. Your next intervention should be: A. Add clonidine patch, 0.2 mg/day B. Add metoprolol SR 50 mg/day C. Ask him to bring in his pill bottles D. Measure renin/aldosterone ratio E. Check renal artery duplex Resistant hypertension Defined as hypertension that persists despite high doses of three drugs including a diuretic Causes: Drugs: not enough or too many Volume overload Secondary hypertension

Drugs: Non-adherence Complex medication regimens Cost concerns Discuss difficulties frequently 1-10 ranking of how likely they are to follow the plan Pill counts Drugs that cause hypertension NSAIDS! Calcineurin inhibitors: cyclosporine, tacrolimus Steroids (and OCPs) Erythropoietin Sympathomimetics: Cocaine, meth, decongestants Herbs: Licorice (real), bitter orange, ephedra Volume overload Excess salt intake Inadequate GFR: consider loop diuretic in CHF, chronic kidney disease Diuretic not given/taken Case: Mrs. P A 32 y/o woman who is 7 months pregnant comes in to see you to stay in touch. BP is 150/90 without proteinuria. The best therapeutic option for her is: A. Hydralazine 10 mg qid B. Methyldopa 250 mg bid C. Labetalol 100 mg bid D. Lisinopril 10 mg qd E. None of the above Hypertension in Pregnancy Mild: 140/90, Severe 160/110 Target: 140-155/90-105 (concern for placental hypoperfusion) Drugs of choice: Labetalol, Methyldopa, Hydralazine Contraindicated: ACE/ARB Case: Mr. M A 33 y/o gentleman comes in for evaluation of blood pressure. He had a BP of 150/94 noted at a health fair. He brings in an outside lab report that is notable for creatinine 0.9, K+ 3.3, UA normal. Which test is most appropriate?

Hyperaldosteronism Hyperaldosteronism Prevalence: 5-15% of hypertensives Symptoms: None Signs: Hypertension & hypokalemia Treatment resistant hypertension Diagnosis Renin/aldosterone ratio 24 hr urine aldosterone (high Na diet) Imaging (CT, Iodocholesterol) Adrenal vein sampling Hyperaldosteronism Management Aldosterone antagonists (less antiandrogenic effects with eplerenone, but $60/mo vs $10-20) Surgery if functional tumor is confirmed Case: Mr. J A 75 y/o man comes in for f/u of his second episode of flash pulmonary edema, now better. BP 154/100, creatinine 1.4 on hydrochlorothiazide and amlodipine. Which test is most appropriate? Renal artery stenosis Renal artery stenosis Prevalence: < 1% of mild hypertension, 10-45% of severe hypertension History: New elevation in BP or creatinine, flash pulmonary edema, atherosclerosis, lack of family history Signs: unilateral abdominal bruit, eye findings of severe hypertension Diagnosis Clinical prediction rule [Krijnen, Annals, 1998] Duplex ultrasonography Angio (MRA, CTA, catheter) MRA not helpful for fibromuscular dyplasia

Renal artery stenosis Management ACE/ARB highly effective but need to watch GFR closely in bilateral disease Medical management has equivalent long-term outcomes and better short-term outcomes than intervention Reserve angioplasty or surgery for those who don t respond to medical management Case: Ms. W A 47 y/o woman comes in complaining of hot flashes and dizziness, and occasional headaches. BP is 180/110, p 100 supine, and 140/60, p 128 standing. Which test is most appropriate? Pheochromocytoma Pheochromocytoma Prevalence: < 0.2% of hypertensives Symptoms: Headache, sweating, palpitations, visual blurring, pallor Signs: tachycardia, orthostatic hypotension, hyperglycemia Diagnosis Plasma free metanephrine (sensitive but 10-15% false positives, often due to medications) 24 hr urine metanephrines Imaging (MR, CT, nuclear medicine) Pheochromocytoma Management NO ß-BLOCKERS Surgery is preferred if possible Pre-op BP management with α-blockers, CCBs Manage crises with IV phentolamine or nitroprusside Case: Ms. F A 44 y/o woman comes in for evaluation of high blood pressure. She previously was normotensive, but over the last 2 years has gained 40 lb. and her blood pressure has gone up to 160/100s. She has to use her arms to get out of the chair. Which test is most appropriate?

Cushing s syndrome Cushing s syndrome Prevalence: < 0.5% of pts with hypertension History: Weight gain, new diabetes, hypertension Signs: Proximal muscle weakness (specific), cushingoid facies, striae, central obesity Diagnosis Dexamethasone suppression test 24-hr urinary cortisol Overnight cortisol/creatinine ratio Midnight salivary cortisol Cushing s syndrome Management Treatment is surgical if lesion is resectable Ketoconazole, mifepristone, paserotide all used in unresectable disease Case: Mr. K A 34 y/o man comes in for evaluation of fatigue. He reports trouble staying awake while at his desk, and has twice fallen asleep at the wheel. BP is 150/90. Which test is most appropriate? Sleep Apnea Consider sleep apnea in patients with refractory hypertension Raw association is strong (OR 3.8) but becomes more nebulous (OR 1.5, p=ns) when adjusted for comorbidities Small studies suggest treatment may help but limited data in resistant HTN Secondary HTN: Other Causes Coarctation: decreased femoral pulses Oral contraceptives Scleroderma renal crisis (use an ACE!) Hypothyroidism (rare) Hyperparathyroidism (rare)

Secondary HTN Principles Use your H&P! It s ok to manage some things medically Be sure to rule out medications (too few/too many) before starting the megaworkup Case: Mr. D A 58 y/o man comes in for evaluation of headache. He reports two days of worsening headache, and now feels foggy. BP is 240/140 and papilledema is present. Which is the best treatment plan? A. Sublingual nifedipine while waiting for medics to arrive B. ICU for IV fenoldopam, target 130/90 C. ICU for IV nitroprusside, target 180/105 D. Amlodipine 10 mg po, recheck 6h E. Furosemide 20 mg po and recheck tomorrow Hypertensive emergency Severe hypertension with acute retinal changes (hemorrhage, exudates, papilledema), acute renal insufficiency, or CNS findings Hypertensive encephalopathy typically nonfocal: headache, nausea, vomiting, altered MS, seizures Hypertensive emergency Treat with IV antihypertensives: nitroprusside, fenoldopam, hydralazine (esp. in eclampsia), labetalol, esmolol, phentolamine Target DBP 100-105 within a few hours; maximum fall in BP should be 25% of initial measurements More rapid lowering increases risk of ischemia